Results 31 to 40 of about 58,806 (288)

Genotyping Analysis of Cryptococcus deuterogattii and Correlation with Virulence Factors and Antifungal Susceptibility by the Clinical and Laboratory Standards Institute and the European Committee on Antifungal Susceptibility Testing Methods

Journal of Fungi, 2023
Data about the relationship between their molecular types, virulence factors, clinical presentation, antifungal susceptibility profile, and outcome are still limited for Cryptococcus deuterogattii.
Leonardo Euripedes Andrade-Silva, Anderson Vilas-Boas, Kennio Ferreira-Paim, Juliana Andrade-Silva, Daniel de Assis Santos, Thatiana Bragine Ferreira, Aercio Sebastião Borges, Delio Jose Mora, Marcia de Souza Carvalho Melhem, Mario Léon Silva-Vergara   +9 more
doaj   +1 more source

Profili di sensibilità agli agenti antifungini di lieviti e miceti lievito-simili isolati negli ospedali torinesi

Microbiologia Medica, 2005
There is an increased incidence of the morbidity and mortality associated with fungal infections caused by resistant fungi in various groups of patients; therefore the monitoring of their susceptibility to antifungal agents to be necessary for optimizing
Vivian Tullio, Janira Roana, Narcisa Mandras, Giuliana Banche, Valeria Allizond, Ornella Cervetti, Michele Panzone, Cristina Crocillà, Ester Gaido, Barbara Fianchino, Maria Agnese Latino, Anna Maria Cuffini, Nicola Carlone   +12 more
doaj   +1 more source

Isolation of Candida africana in oral candidiasis: First report among cancer patients in Iran [PDF]

Current Medical Mycology, 2020
Background and Purpose: Oropharyngeal candidiasis (OPC) is a fungal infection of the oral cavity caused by the members of C. albicans complex. Although C.
Ensieh lotfali, Masoud Mardani, sara Abolghasemi, David Darvishnia, Mohammad Mahdi Rabiei, Reza Ghasemi, Azam Fattahi   +6 more
doaj   +1 more source

Minimum Inhibitory Concentration (MIC) Assay for Antifungal Drugs

Bio-Protocol, 2012
The Minimum Inhibitory Concentration (MIC) Assay is widely used to measure the susceptibility of yeasts to antifungal agents. In serial two-fold dilutions, the lowest concentration of antifungal drug that is sufficient to inhibit fungal growth is the MIC.
Lucy Xie, Sheena Singh-Babak, Leah Cowen   +2 more
doaj   +1 more source

Issues in antifungal susceptibility testing [PDF]

Journal of Antimicrobial Chemotherapy, 2008
In line with the availability of an increasing array of systemic antifungal agents, there is a need for accurate, reproducible and predictive susceptibility testing of fungal isolates in order to help inform clinical choice. Much early attention on antifungal susceptibility testing focused on defining test parameters that produced reproducible and ...
openaire   +2 more sources

Antifungal Susceptibilities ofPaecilomycesSpecies [PDF]

Antimicrobial Agents and Chemotherapy, 1998
ABSTRACTThe MICs and minimum fungicidal concentrations (MFCs) of amphotericin B, miconazole, itraconazole, ketoconazole, fluconazole, and flucytosine for 52 isolates ofPaecilomycesspecies were evaluated by the broth microdilution method, largely based on the recommendations of the National Committee for Clinical Laboratory Standards (document M27-A ...
C, Aguilar, I, Pujol, J, Sala, J, Guarro
openaire   +2 more sources

Well diffusion for antifungal susceptibility testing [PDF]

International Journal of Infectious Diseases, 2004
The increasing clinical and microbiologic resistance of Candida spp. isolates to several antifungal agents is becoming a serious problem. It is now reasonable to propose the use of antifungal susceptibility testing in Candida spp. isolates from patients who have failed conventional therapy, before the selection of an empirical therapy.One hundred and ...
Magaldi, S, Mata-Essayag, S, Hartung de Capriles, C, Perez, C, Colella, M.T, Olaizola, Carolina, Ontiveros, Yudith   +6 more
openaire   +2 more sources

Determination of antifungal susceptibility patterns among the clinical isolates of Candida species

Journal of Global Infectious Diseases, 2011
Context: Candida species are opportunistic yeasts that cause infections ranging from simple dermatosis to potentially life-threatening fungemia. The emergence of resistance to antifungal drugs has been increased in the past two decades.
Kamiar Zomorodian, Mohammad Javad Rahimi, Kayvan Pakshir, Marjan Motamedi, Moosa Rahimi Ghiasi, Hasanein Rezashah   +5 more
doaj   +1 more source

New approaches for antifungal susceptibility testing [PDF]

Clinical Microbiology and Infection, 2017
Invasive fungal diseases, including those caused by (multi)drug-resistant Candida and Aspergillus species, still represent global public health concerns. Information about the antifungal susceptibility testing (AFST) of fungal isolates must be quickly produced to help clinicians in administrating appropriate antifungal therapies.
Sanguinetti, Maurizio, Posteraro, Brunella   +1 more
openaire   +2 more sources

Host‐Directed Biomaterials for Combatting Bloodstream Infections: From Macrocyclic Peptides to Immune‐Activating Cell Backpacks

Advanced Functional Materials, EarlyView.
Bloodstream infections (BSI) are one of the leading causes of mortality and morbidity in both civilian and military populations. This paper summarizes recent progress in novel treatment strategies to manage BSI arising from both bacterial and fungal pathogens using molecules, particles, and materials to elicit host‐directed immunity.
Thomas Thomou, Jagadish Krishnappa, Justin B. Schaal, Prasad Tongaonkar, Dat Q. Tran, Wenchao Gu, Yung‐Fu Chang, Michael E. Selsted, Shaoyi Jiang, Samir Mitragotri, Michael Super, Christopher J. Bettinger   +11 more
wiley   +1 more source